Chen, C., Chen, C., Chuang, W., Leu, Y., Ueng, S., Hsueh, C., . . . Wang, T. (2020). Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells. Front Oncol.
Chicago Style CitationChen, Chi-Yuan, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Chuen Hsueh, Chau-Ting Yeh, and Tong-Hong Wang. "Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells." Front Oncol 2020.
MLA CitationChen, Chi-Yuan, et al. "Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells." Front Oncol 2020.
Warning: These citations may not always be 100% accurate.